Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00780806 | Safety And Blood Collection Study Of Meningococcal B Rlp2086 Vaccine In Adults | PHASE1 | COMPLETED | 60 | — | — | Oct 1, 2008 | May 1, 2010 | Aug 23, 2011 | 3 | Australia |
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | Immunization with one dose of MnB rLP2086 vaccine at 0, 1 and 6 months |
| Name | Type | Description |
|---|---|---|
| meningococcal B rLP2086 vaccine candidate | BIOLOGICAL | vaccine, 0.5 mL, 3 doses, 0 - 2 - 6 to 9 months |
| Blood draw | PROCEDURE | Blood draw |
Inclusion Criteria: * Healthy male or female subject between the ages of \>=18 and \<=40 years * Negative urine pregnancy test for all female subjects of childbearing potential prior to test article administration and at the completion of the study. * All female or male subjects who are biologicall...